Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Update! With 2 new 13D

$Cartesian Therapeutics (RNAC.US)$ Cartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buy

Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Murat Kalayoglu(19.9%),Seven One Eight Three Four Irrevocable Trust(17.1%), etc.
SEC announcement
13 mins ago

Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Michael Singer(4.3%),Baharak Asefzadeh(2.6%), etc.
SEC announcement
19 mins
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
7
Translate
Report
6155 Views
Comment
Sign in to post a comment
3467Followers
27Following
52KVisitors
Follow